Jabbour Jerome D has filed 3 insider transactions across 2 companies since December 2023.
Most recent transaction: a grant/award of 25000 shares of Indaptus Therapeutics, Inc. ($INDP) on February 26, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 26, 2026 | Indaptus Therapeutics, Inc. | $INDP | Jabbour Jerome D | Director | A | Option to Buy Common Stock | 25000 | $0.00 | 25,000.0000 | 1,641,920 | 9999.99% | 1.52% |
| April 30, 2025 | Matinas BioPharma Holdings, Inc. | $MTNB | Jabbour Jerome D | President and CEO | A | Stock Option (right to Buy) | 70100 | $0.00 | 70,100.0000 | 5,086,985 | 9999.99% | 1.38% |
| Dec. 15, 2023 | Matinas BioPharma Holdings, Inc. | $MTNB | Jabbour Jerome D | President and CEO | A | Stock Option (right to Buy) | 3500000 | $0.00 | 3,500,000.0000 | 0 | 9999.99% | 0.00% |